287 related articles for article (PubMed ID: 1428134)
1. Comparative study of oral versus injectable vitamin K in neonates.
Malik S; Udani RH; Bichile SK; Agrawal RM; Bahrainwala AT; Tilaye S
Indian Pediatr; 1992 Jul; 29(7):857-9. PubMed ID: 1428134
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of oral water soluble vitamin K in neonates.
Sen S; Kumari S; Narayan S; Bains C; Dutta AK
Indian Pediatr; 1989 Oct; 26(10):992-5. PubMed ID: 2630463
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral water soluble vitamin K on PIVKA-II levels in newborns.
Sharma RK; Marwaha N; Kumar P; Narang A
Indian Pediatr; 1995 Aug; 32(8):863-7. PubMed ID: 8635828
[TBL] [Abstract][Full Text] [Related]
4. [Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].
Arteaga-Vizcaíno M; Espinoza Holguín M; Torres Guerra E; Diez-Ewald M; Quintero J; Vizcaíno G; Estévez J; Fernández N
Rev Med Chil; 2001 Oct; 129(10):1121-9. PubMed ID: 11775338
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K prophylaxis in the neonates by oral route with different dosages.
Pintadit P; Isarangkura PB; Chalermchandra K; Pongcharoen S; Sasanakul W; Chulajata R; Green GM
J Med Assoc Thai; 1989 Jan; 72 Suppl 1():125-9. PubMed ID: 2732633
[TBL] [Abstract][Full Text] [Related]
6. Parenteral vitamin K1: the effective prophylaxis against haemorrhagic disease for all newborn infants.
Clarkson PM; James AG
N Z Med J; 1990 Mar; 103(885):95-6. PubMed ID: 2179775
[No Abstract] [Full Text] [Related]
7. Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries.
van Hasselt PM; de Koning TJ; Kvist N; de Vries E; Lundin CR; Berger R; Kimpen JL; Houwen RH; Jorgensen MH; Verkade HJ;
Pediatrics; 2008 Apr; 121(4):e857-63. PubMed ID: 18381514
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin time in first week of life with special reference to vitamin K administration.
Mathur GP; Mathur S; Goenka R; Bhalla JN; Agarwal A; Tripathi VN
Indian Pediatr; 1990 Jul; 27(7):723-5. PubMed ID: 2246044
[TBL] [Abstract][Full Text] [Related]
9. [Prothrombin and acarboxyprothrombin activity in neonates after oral and intramuscular administration of vitamin K].
Goldschmidt B; Verbényi M; Kovács I; Ilin E; Varga K; Német T
Orv Hetil; 1990 Mar; 131(11):577-82. PubMed ID: 2314877
[TBL] [Abstract][Full Text] [Related]
10. [General vitamin K prevention in newborn infants].
Muntean W
Z Geburtshilfe Perinatol; 1986; 190(3):107-13. PubMed ID: 3765750
[TBL] [Abstract][Full Text] [Related]
11. Administration of Vitamin K to newborns: implications and recommendations.
McMillan DD
CMAJ; 1996 Feb; 154(3):347-9. PubMed ID: 8564904
[TBL] [Abstract][Full Text] [Related]
12. Use of oral vitamin K for prevention of late vitamin k deficiency bleeding in neonates when injectable vitamin K is not available.
Ipema HJ
Ann Pharmacother; 2012 Jun; 46(6):879-83. PubMed ID: 22619475
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K administration in neonates: survey of compliance with recommended practices in the Dunedin area.
Doran O; Austin NC; Taylor BJ
N Z Med J; 1995 Aug; 108(1006):337-9. PubMed ID: 7566761
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K during infancy: current status and recommendations.
Singh M
Indian Pediatr; 1997 Aug; 34(8):708-12. PubMed ID: 9492399
[TBL] [Abstract][Full Text] [Related]
15. Controversies surrounding the administration of vitamin K to newborns: a review.
Brousson MA; Klein MC
CMAJ; 1996 Feb; 154(3):307-15. PubMed ID: 8564900
[TBL] [Abstract][Full Text] [Related]
16. Vitamin K prophylaxis for premature infants: 1 mg versus 0.5 mg.
Costakos DT; Greer FR; Love LA; Dahlen LR; Suttie JW
Am J Perinatol; 2003 Nov; 20(8):485-90. PubMed ID: 14703597
[TBL] [Abstract][Full Text] [Related]
17. [Administration of vitamin K to neonates and infants].
Uitentuis J
Ned Tijdschr Geneeskd; 1990 Aug; 134(34):1642-6. PubMed ID: 2215706
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K prophylaxis in the neonate by the oral route and its significance in reducing infant mortality and morbidity.
Isarangkura PB; Bintadish P; Tejavej A; Siripoonya P; Chulajata R; Green GM; Chalermchandra K
J Med Assoc Thai; 1986 Oct; 69 Suppl 2():56-61. PubMed ID: 3805949
[TBL] [Abstract][Full Text] [Related]
19. Should intramuscular vitamin K prophylaxis for haemorrhagic disease of the newborn be continued? A decision analysis.
Brown SG; McHugh G; Shapleski J; Wotherspoon PA; Taylor BJ; Gillett WR
N Z Med J; 1989 Jan; 102(860):3-5. PubMed ID: 2643775
[TBL] [Abstract][Full Text] [Related]
20. Prevention of subclinical vitamin K deficiency based on PIVKA-II levels: oral versus intramuscular route.
Bakhshi S; Deorari AK; Roy S; Paul VK; Singh M
Indian Pediatr; 1996 Dec; 33(12):1040-3. PubMed ID: 9141807
[No Abstract] [Full Text] [Related]
[Next] [New Search]
